Nicholas F Hrisomalos

Learn More
PURPOSE To assess the role of bevacizumab in inflammatory ocular neovascularization. DESIGN Retrospective, multicenter, consecutive case series of inflammatory ocular neovascularization. METHODS Patients with inflammatory ocular neovascularization of varying causes for whom standard therapy failed were treated with intravitreal injection of bevacizumab.(More)
The authors describe in seven eyes of four patients a form of serpiginous choroiditis beginning in the macula without initial peripapillary activity. Eyes with macular serpiginous choroiditis often had a poor visual prognosis and sometimes developed subretinal neovascularization. Fluorescein angiography of the acute lesions showed hypofluorescence; some(More)
OBJECTIVE To assess the 3-year visual outcome of intravitreal bevacizumab in inflammatory ocular neovascularization. DESIGN Experimental study. METHODS Retrospective multicenter consecutive case series in 81 patients with inflammatory ocular neovascularization refractory to standard therapy and treated with intravitreal bevacizumab. The outcome measures(More)
PURPOSE To assess the long-term role of bevacizumab (Avastin; Genentech Inc, South San Francisco, California, USA) in inflammatory ocular neovascularization. DESIGN Retrospective multicenter consecutive case series of inflammatory ocular neovascularization. METHODS settings: Multicenter institutional and private practices. STUDY POPULATION Patients(More)
Six patients with proliferative sickle cell retinopathy and vitreous bands were treated with the neodymium-YAG (Nd-YAG) laser to accomplish lysis of avascular traction bands or to clear the media in front of the macula. Transection of bands was possible in five of the six cases but in two of these the effect was only partial. Three cases were satisfactorily(More)
OBJECTIVE To report a previously undescribed clinical entity involving an unusual inflammatory lesion of the choroid. PATIENTS Six young, healthy patients experienced acute unilateral visual loss secondary to unifocal choroiditis in the macula. RESULTS All patients exhibited a solitary, elevated, yellow-white active focus of choroiditis with overlying(More)
To the Editor: Prolonged gas tamponade is used for a variety of vitreoretinal repair procedures. Long-acting gases, such as C3F8, commonly linger for 4 weeks to 6 weeks or longer. It is imperative that a means of identification of the gas is visible on the patient until the bubble has resolved; not doing so could put the patient at a high risk of vision(More)